Innate Pharma S.A. IPHA
Set alert
1.39 USD -0.07 -4.79%
As of Nov 2, 1:48 PM ET
1.38 Day range 1.44
1.17 52-week range 2.71
- YTD
- -20.57%
- 1 year
- -29.44%
- Open
- 1.44
- Prev close
- 1.46
- Mkt cap
- 155.26M
- Vol
- 19.19K
- Avg vol
- 159.36K
- EPS
- -0.59
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.38
- High
- 1.44
- Forward P/E
- 4.67
- Beta
- 0.87
- Short ratio
- 5.63
- Inst. own
- 0.50%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 21, 2024
- 50-d avg
- 1.82
- 200-d avg
- 2.23
- 1y target
- 7.41
Ownership
Held by insiders 0.00%
Held by institutions 0.50%
Float held by institutions 0.50%
Institutions 11
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Optiver Holding B.v. | 0.10% | 86,788 | 182.25K | Sep 29, 2024 |
| Exchange Traded Concepts LLC | 0.09% | 77,350 | 162.43K | Sep 29, 2024 |
| Morgan Stanley | 0.05% | 43,524 | 91.40K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.03% | 21,267 | 44.66K | Sep 29, 2024 |
| UBS Group AG | 0.01% | 8,408 | 17.66K | Sep 29, 2024 |
| Rhumbline Advisers | 0.00% | 205 | 430 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ETF Series Solutions-Range Cancer Therapeutics ETF | 0.09% | 73,688 | 154.74K | Aug 30, 2024 |
| Trust for Professional Managers-ActivePassive International Equity ETF | 0.08% | 64,826 | 136.13K | Aug 30, 2024 |
Insiders
No insider holdings on record